| News

BGO Software establishes branch in Basel

03.06.2021

The Bulgarian firm BGO Software has now established a presence in Basel after founding BGO Software und Technologie GmbH. The company develops solutions for use in the research and healthcare sector. It now intends to carry out further development work in Switzerland from its base at the Switzerland Innovation Park Basel Area.

Ivan Lekushev, CEO of BGO Software (img: BGO Software)

Founded in 2008, BGO Software has its roots in the Bulgarian capital of Sofia. Over the past decade, the company has become established on the back of developing solutions for major Swiss life sciences firms and the Health Research Authority in the UK (NHS). Since 2020, it has specialized exclusively in digital healthcare solutions, and has now turned its attention to further developing in Switzerland by establishing a new branch headquartered at the Switzerland Innovation Park Basel Area, details of which can be found in a press release. Alongside London, the Basel location will act as a second headquarters, with research and development activities being driven forward in Sofia.

BGO Software teamed up with the investment and innovation promotion agency Basel Area Business & Innovation for the location search. Basel Area operates the Switzerland Innovation Park Basel Area, at whose Novartis Campus site the new Swiss branch BGO Software und Technologie GmbH is now located. However, the agency’s support went far beyond finding the right contact person. For example, Basel Area provided BGO Software with information related to the life sciences ecosystem in the region in addition to holding consultations with tax advisors. “With the choice of Basel Area as the location for our development in Switzerland, BGO Software has now arrived at the heart of innovation within the healthcare and MedTech sector as a company and center of expertise”, explains Ivo Stoicov, Managing Partner of BGO Software. He adds: “Basel is a location with global impact. We are looking forward to the diverse opportunities, challenges and new business partners it has to offer”.

BGO Software will now focus on advancing the development of innovative digital healthcare solutions from its Basel site. Up to now, it has developed solutions such as the HARP database, which played a key role in the NHS rapidly moving to approve the world’s first COVID-19 vaccine for mass use, according to the press release. Products for patient engagement, digital therapeutics and electronic patient files are also part of the BGO Software portfolio. The CEO of BGO Software, Ivan Lekushev, underlined that with the Basel Area the company has now found the perfect location to focus on generating optimum customer outcomes: “Basel is the perfect place with a wealth of digital solutions in the field of digital healthcare, the primary focus of our company”. At the new location at the Switzerland Innovation Park Basel Area, BGO Software will now also enjoy the added bonus of proximity to its customers and partners.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

Alentis secures 67 million US dollars
Basel Area Business & Innovation, Innovation, Invest

Alentis secures 67 million US dollars

The Basel-based biotechnology company Alentis Therapeutics has secured 67 million US dollars in a series B funding round. The funds...

Read More
RocketVax secures partners for coronavirus vaccine in Basel
Basel Area Business & Innovation, Innovation

RocketVax secures partners for coronavirus vaccine in Basel

RocketVax has found cooperation partners for the development of its innovative coronavirus vaccine. The University Hospital of Basel, the University...

Read More
Bright Peak secures investment of 107 million dollars
Basel Area Business & Innovation, Innovation, Invest

Bright Peak secures investment of 107 million dollars

Bright Peak has raised a total of 107 million US dollars as part of a financing round. The biotechnology firm...

Read More
LCB lands major contract
Basel Area Business & Innovation, Innovation, Invest

LCB lands major contract

LCB Sàrl is active in the areas of Human Machine Interface as well as software and electronics development. The company...

Read More
Scailyte now calls Basel home
Basel Area Business & Innovation, Innovation, Invest, Switzerland Innovation Park

Scailyte now calls Basel home

The biotechnology firm Scailyte is now installed at the Novartis Campus of Switzerland Innovation Park Basel Area. Scailyte develops solutions...

Read More
1 2 3 45

Do you have a question? We'd like to hear from you.